92519 ⎘
Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and acyclic the nitrogen atom of the amino group being further bound to hydrocarbon groups substituted by hydroxy groups
CO-CRYSTALS
#2ADDITIVE FOR SURFACE ACTIVATION, AND EMULSION COMPOSITION USING SAME
#3BIODEGRADABLE UV ABSORBERS
#4Immunomodulator compounds
#5Methods of reducing color in alkanolamine compositions and compositions produced thereby
#6Immunomodulator compounds
#7AMINE SYNERGISTS
#8Organic crystalline salt of haloacetic acid
#9NRF2 activators
#10STEROIDS AS AGONISTS FOR FXR
#11Organic Amine Salt Compound Having Anions Serving as CO2 Donors and Application of Same as Foaming Agent
#12Methods of reducing color in alkanolamine compositions and compositions produced thereby
#13Synergistic compositions
#14N-type thermoelectric conversion layer, thermoelectric conversion element, and composition for forming N-type thermoelectric conversion layer
#15Clickable antimicrobial molecules and polymers
#16Adhesive composition, bio-electrode, method for manufacturing a bio-electrode, and salt
#17Immunomodulator compounds
#18Synergistic compositions
#19Steroids as agonists for FXR
#20POLYETHER POLYOL PROVIDING GOOD BLOW-GEL BALANCE FOR POLYURETHANE PRODUCTS MADE THEREFROM
#21Biocatalyst solvent using ionic liquid, and biocatalyst solution containing biocatalyst and said solvent
#22Storage-stable dye solutions
#23Steroids as agonists for FXR
#24Synergistic compositions
#25Hydroxy compound, ion conducting agent, and electroconductive resin composition
#26Synthesis of deuterated morpholine derivatives
#27Synthetic analogs of sphingolipids
#28Sorbent comprising on its surface a cationic or protonizable aliphatic residue for the purification of organic molecules
#29Liquids
#30Aminoalcohol compounds and their use as zero or low VOC additives for paints and coatings
#31Compounds for use in the treatment of immune related inflammatory disease
#32Chemoselective enrichment for compound isolation
#33SALTS OF FENOFIBRIC ACID AND PHARMACEUTICAL FORMULATIONS THEREOF
#34Method for preparing higher ethanolamines
#35Steroids as agonists for FXR
#36Alkoxylated alkylamines/alkyl ether amines with peaked distribution
#37Process for preparing pure triethanolamine (TEOA)
#38Liquids
#39Composition comprising a pesticide and an alkoxylate of 2-propylheptylamine
#40Synthetic analogs of sphingolipids
#41Hydrolytically stable phosphite compositions
#42Synthesis of deuterated morpholine derivatives
#43Transalkoxylation of nucleophilic compounds
#44Methods for making ethanolamine(s) and ethyleneamine(s) from ethylene oxide and ammonia, and related methods
#45Steroids as agonists for FXR
#46SALTS OF FENOFIBRIC ACID AND PHARMACEUTICAL FORMULATIONS THEREOF
#47Alkoxylated alkylamines/alkyl ether amines with peaked distribution
#48Salts of Fenofibric Acid and Pharmaceutical Formulations Thereof
#49Process for improving the conversion of oxazolidones to alkanolamines
#50Preparation of alkanolamines
#51Method for producing triethanolamine
#52Methods and compositions for the efficient delivery of therapeutic agents to cells and animals
#53Liquids
#54Steroids as agonists for FXR
#55Preparation of alkanolamines
#56Method for separating triethanolamin from a mixture obtainable by ammonia and ethylene oxide reaction
#57Salts of fenofibric acid and pharmaceutical formulations thereof
#58Steroids as agonists for FXR